The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre “CE-approval cohort”
EuroIntervention 2017;13:e1040-e1046 published online August 2017 published online e-edition October 2017. DOI: 10.4244/EIJ-D-17-00187
Helge Möllmann1,2*, MD; Thomas Walther3, MD; Dimytri Siqueira4, MD; Patrick Diemert5, MD; Hendrik Treede6, MD; Eberhard Grube7, MD; Georg Nickenig7, MD; Stephan Baldus8, MD; Tanja Rudolph8, MD; Toru Kuratani9, MD; Yoshiki Sawa10, MD; Joerg Kempfert3,11, MD; Won-Keun Kim1,3, MD; Alexandre Abizaid4,12, MD
1. Department of Cardiology, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany; 2. Department of Internal Medicine-I, Cardiology, St. Johannes-Hospital, Dortmund, Germany; 3. Department of Cardiac Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim,
Aims: The aim of this study was to assess the safety and performance of the ACURATE neo transcatheter heart valve and its transfemoral delivery system.